SAMMARTANO, VINCENZO
 Distribuzione geografica
Continente #
EU - Europa 1.832
NA - Nord America 1.512
AS - Asia 1.076
SA - Sud America 198
AF - Africa 59
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 4.681
Nazione #
US - Stati Uniti d'America 1.459
RU - Federazione Russa 584
SG - Singapore 374
IT - Italia 356
CN - Cina 274
IE - Irlanda 217
DE - Germania 183
BR - Brasile 160
GB - Regno Unito 132
FI - Finlandia 123
VN - Vietnam 104
HK - Hong Kong 85
FR - Francia 77
SE - Svezia 60
KR - Corea 56
IN - India 54
BD - Bangladesh 37
ZA - Sudafrica 36
CA - Canada 34
NL - Olanda 22
AR - Argentina 15
MX - Messico 15
PL - Polonia 14
JP - Giappone 13
ES - Italia 11
IQ - Iraq 11
AT - Austria 10
CZ - Repubblica Ceca 9
PK - Pakistan 8
TR - Turchia 8
UA - Ucraina 8
CO - Colombia 6
EC - Ecuador 6
IR - Iran 6
EG - Egitto 5
ID - Indonesia 5
LT - Lituania 5
SA - Arabia Saudita 5
KE - Kenya 4
MY - Malesia 4
UZ - Uzbekistan 4
AL - Albania 3
AU - Australia 3
BO - Bolivia 3
CH - Svizzera 3
ET - Etiopia 3
MA - Marocco 3
NP - Nepal 3
PY - Paraguay 3
AE - Emirati Arabi Uniti 2
AM - Armenia 2
CI - Costa d'Avorio 2
CL - Cile 2
DO - Repubblica Dominicana 2
HR - Croazia 2
IL - Israele 2
JO - Giordania 2
KG - Kirghizistan 2
KH - Cambogia 2
LA - Repubblica Popolare Democratica del Laos 2
LB - Libano 2
MD - Moldavia 2
NG - Nigeria 2
OM - Oman 2
PH - Filippine 2
TN - Tunisia 2
VE - Venezuela 2
BE - Belgio 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
CR - Costa Rica 1
DZ - Algeria 1
GR - Grecia 1
JM - Giamaica 1
LU - Lussemburgo 1
MK - Macedonia 1
MN - Mongolia 1
NO - Norvegia 1
PT - Portogallo 1
RO - Romania 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
TL - Timor Orientale 1
UG - Uganda 1
UY - Uruguay 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 4.681
Città #
Dallas 279
Singapore 268
Dublin 216
Moscow 151
Munich 135
San Jose 135
Ashburn 134
Santa Clara 99
Hefei 91
Helsinki 85
Hong Kong 80
Southend 76
Siena 73
Beijing 66
Chandler 58
Seoul 54
New York 52
Los Angeles 46
Fairfield 45
Council Bluffs 40
Ho Chi Minh City 37
Florence 36
The Dalles 34
Johannesburg 32
Lauterbourg 31
Milan 26
Woodbridge 24
Turku 23
São Paulo 22
Hanoi 21
Rome 21
Cambridge 20
Seattle 19
Houston 17
Princeton 17
Shanghai 16
Buffalo 15
Nuremberg 15
Bengaluru 14
Turin 14
Wilmington 14
Lappeenranta 13
Chennai 12
Chicago 12
Warsaw 12
Frankfurt am Main 11
Orem 11
Portsmouth 11
Redondo Beach 11
Denver 10
London 10
San Francisco 10
Messina 9
Montreal 9
Rio de Janeiro 9
Tokyo 9
Toronto 9
Washington 9
Atlanta 8
Brooklyn 8
Mumbai 8
Boston 7
Da Nang 7
Boardman 6
Brno 6
Vienna 6
Dearborn 5
Fremont 5
Haiphong 5
Mexico City 5
Naples 5
Querétaro 5
San Diego 5
Stockholm 5
Vancouver 5
Bergamo 4
Columbus 4
Dong Ket 4
Manchester 4
Miami 4
Modena 4
Phoenix 4
Poplar 4
Porto Alegre 4
San Mateo 4
Secaucus 4
Tashkent 4
Amsterdam 3
Baghdad 3
Biên Hòa 3
Brasília 3
Buscate 3
Cape Town 3
City of London 3
Como 3
Curitiba 3
Dhaka 3
Düsseldorf 3
Giza 3
Grosseto 3
Totale 3.016
Nome #
Antibody and B-cell responses in myelofibrosis patients after the third doses of mRNA SARS-CoV-2 vaccines 290
Long-Term Safety of Rapid Daratumumab Infusions in Multiple Myeloma Patients 251
Real-world experience with decitabine as a first-line treatment in 306 elderly acute myeloid leukaemia patients unfit for intensive chemotherapy 242
A BRAF Negative Classic Hairy Cell Leukemia Patient in Long Lasting Complete Remission after Rituximab and Pentostatin 230
A case of acquired factor XIII deficiency secondary to plasmablastic lymphoma 227
Efficacy and safety of eltrombopag during conception and first trimester of pregnancy in a case of refractory severe immune thrombocytopenia 216
Antibody response in myelofibrosis patients after three doses of mRNA SARS-CoV-2 vaccine 208
First reported case of secondary mixed phenotype acute leukemia after multiple myeloma 202
The third dose of mRNA SARS-CoV-2 vaccines enhances the spike-specific antibody and memory B cell response in myelofibrosis patients 192
Cladribine Efficacy in a Patient with Hairy Cell Leukemia and Severe Renal Insufficiency 187
Real-life experience of edoxaban treatment for venous thromboembolism (VTE)/pulmonary embolism (PE) in patients with isolated positive Lupus Anticoagulant (LAC) during the COVID-19 pandemic lockdown in Italy 184
Safety of COVID-19 mRNA vaccination in patients with history of acquired hemophilia A: a case series 175
Daratumumab in AL Amyloidosis: A Real-Life Experience of the "RTM" (Regional Tuscan Myeloma Network) 175
Prognostic value of CD47 overexpression measured by flow cytometry in patients with acute myeloid leukemia 174
Prospective monitoring of Chronic Myeloid Leukemia Patients from Time of TKI Discontinuation: the fate of Peripheral Blood CD26+ Leukemia Stem Cells 173
Efficacy and safety of ruxolitinib for Covid-19 related acute respiratory distress syndrome in a patient with blastic plasmacytoid dendritic cell neoplasm (leukemic variant) 163
Peripheral Blood CD26+ Leukemia Stem Cells Monitoring in Chronic Myeloid Leukemia Patients from Diagnosis to Response to TKIs: Interim Results of a Multicenter Prospective Study (PROSPECTIVE FLOWERS) 153
Functional imaging in the evaluation of treatment response in multiple myeloma: the role of PET-CT and MRI 149
Pro-Inflammatory and Pro-Oxidative Changes During Nilotinib Treatment in CML Patients: Results of a Prospective Multicenter Front-Line TKIs Study (KIARO Study) 147
The slower antibody response in myelofibrosis patients after two doses of MRNA sars-COV-2 vaccine calls for a third dose 142
Therapeutic Vaccinations with p210 Peptides in Imatinib-Treated Chronic Myeloid Leukemia Patients: 10 Years Follow-Up of GIMEMA CML0206 and SI0207 Studies 141
Anti-BCMA novel therapies for multiple myeloma 137
Central nervous system myeloma and unusual extramedullary localizations: real life practical guidance 134
Prognostic value of CD47 overexpression measured by flow cytometry in acute myeloid leukemia 130
Minimal Residual Disease Significance in Multiple Myeloma Patients Treated with Anti-CD38 Monoclonal Antibodies 129
Therapeutic Management of Patients with FLT3 + Acute Myeloid Leukemia: Case Reports and Focus on Gilteritinib Monotherapy 115
Finding the balance between immunoparesis recovery and multiple myeloma responses after autologous stem cell transplantation in the era of maintenance therapy and novel drugs 106
MRD-negative conversion with daratumumab monotherapy in newly diagnosed multiple myeloma patients in ≥VGPR/MRD-positive after first-line therapy: Final analysis of the open-label, single-arm multicentric phase 2 trial DART4MM 16
Totale 4.788
Categoria #
all - tutte 15.570
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.570


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20219 0 0 0 0 0 0 0 0 0 0 0 9
2021/2022146 11 8 10 19 1 5 2 3 5 13 33 36
2022/2023330 13 32 35 33 23 37 24 32 23 6 66 6
2023/2024491 9 14 48 32 30 114 157 16 13 27 4 27
2024/20251.118 34 31 99 54 86 106 96 87 119 50 134 222
2025/20262.469 170 301 265 392 595 102 230 52 65 153 71 73
Totale 4.788